Literature DB >> 27608946

Novel chinmedomics strategy for discovering effective constituents from ShenQiWan acting on ShenYangXu syndrome.

Xiao-Hang Zhou1, Ai-Hua Zhang1, Liang Wang1, Yun-Long Tan1, Yu Guan1, Ying Han1, Hui Sun1, Xi-Jun Wang2.   

Abstract

Elucidation of the efficacy of traditional Chinese medicine (TCM) is of importance for scientists of modern medicine to understand the value of TCM clinical experience, and it is necessary to have a biological language to scientifically describe the efficacy of TCM. With this background?Chinmedomics has been proposed by our team, which includes integrating serum pharmacochemistry and metabolomics technology, defining theory and research methods for expressing the efficacy of TCMs based on the biomarkers discovery of TCM syndrome and elucidating the efficacy of TCM formulae, discovering effective constituents, and finally elucidating the scientific value of TCM. In the present study, the innovative chinmedomics strategy was conducted to evaluate the therapeutic effects of ShenQiWan (SQW) acting on ShenYangXu (kidney-yang deficiency syndrome, KYDS). We analyzed the urine metabolic trajectory between the model and control groups, and identified the biomarkers by the multivariate analysis. We found that SQW caused significant restoration of abnormal metabolism of KYDs. Using the method of metabolomics, 17 potential urine biomarkers were analyzed through 4 repeated tests in our serial studies on SQW and KYDS. Under the premise of therapeutic efficacy, a total of 56 peaks were tentatively characterized in vivo by the use of serum pharmacochemistry. Correlation analysis between marker metabolites and in vivo constituents of SQW showed that 28 compositions had a close relationship with urine biomarkers of therapeutic effects, whichmight play a key role in the therapeutic effect of SQW. These compounds were imported into an online database to predict their targets. Twenty-three important potential targets were identified, which were related to the metabolism of steroid hormone, tryptophan utilization, and thyroid hormone. In conclusion, chinmedomics is a useful strategy for discovery of potentially effective constituents from complex TCM formulae.
Copyright © 2016 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chinmedomics; Metabolomics; Serum pharmacochemistry; ShenQiWan; ShenYangXu syndrome

Mesh:

Substances:

Year:  2016        PMID: 27608946     DOI: 10.1016/S1875-5364(16)30067-X

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  8 in total

Review 1.  Recent advances and effective strategies in the discovery and applications of natural products.

Authors:  Jing Xie; Ai-Hua Zhang; Hui Sun; Guang-Li Yan; Xi-Jun Wang
Journal:  RSC Adv       Date:  2018-01-03       Impact factor: 4.036

2.  High-throughput chinmedomics-based prediction of effective components and targets from herbal medicine AS1350.

Authors:  Qi Liu; Aihua Zhang; Liang Wang; Guangli Yan; Hongwei Zhao; Hui Sun; Shiyu Zou; Jinwei Han; Chung Wah Ma; Ling Kong; Xiaohang Zhou; Yang Nan; Xijun Wang
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

3.  Functional metabolomics using UPLC-Q/TOF-MS combined with ingenuity pathway analysis as a promising strategy for evaluating the efficacy and discovering amino acid metabolism as a potential therapeutic mechanism-related target for geniposide against alcoholic liver disease.

Authors:  Shi Qiu; Ai-Hua Zhang; Yu Guan; Hui Sun; Tian-Lei Zhang; Ying Han; Guang-Li Yan; Xi-Jun Wang
Journal:  RSC Adv       Date:  2020-01-15       Impact factor: 4.036

4.  Functional metabolomics discover pentose and glucuronate interconversion pathways as promising targets for Yang Huang syndrome treatment with Yinchenhao Tang.

Authors:  Hui Sun; Ai-Hua Zhang; Qi Song; Heng Fang; Xing-Yuan Liu; Jing Su; Le Yang; Meng-Die Yu; Xi-Jun Wang
Journal:  RSC Adv       Date:  2018-10-31       Impact factor: 4.036

5.  Serum metabolomics strategy for understanding the therapeutic effects of Yin-Chen-Hao-Tang against Yanghuang syndrome.

Authors:  Xing-Yuan Liu; Ai-Hua Zhang; Heng Fang; Meng-Xi Li; Qi Song; Jing Su; Meng-Die Yu; Le Yang; Xi-Jun Wang
Journal:  RSC Adv       Date:  2018-02-15       Impact factor: 4.036

6.  High-throughput metabolomics used to identify potential therapeutic targets of Guizhi Fuling Wan against endometriosis of cold coagulation and blood stasis.

Authors:  Xiu-Hong Wu; Chuang Zhao; Ai-Hua Zhang; Jin-Qi Zhang; Xu Wang; Xiao-Lan Sun; Ze Sun; Xi-Jun Wang
Journal:  RSC Adv       Date:  2018-05-24       Impact factor: 4.036

7.  Effect of Wuzi Yanzong prescription on oligoasthenozoospermia rats based on UPLC-Q-TOF-MS metabolomics.

Authors:  Zhimin Chen; Baohua Dong; Yunxiu Jiang; Ying Peng; Wenbing Li; Lingying Yu; Yongxiang Gao; Changjiang Hu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 8.  Chinmedomics, a new strategy for evaluating the therapeutic efficacy of herbal medicines.

Authors:  Ying Han; Hui Sun; Aihua Zhang; Guangli Yan; Xi-Jun Wang
Journal:  Pharmacol Ther       Date:  2020-09-18       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.